Urinary tract antiseptics

Area of Science:

• Pharmacology
• Infectious Diseases
• Urology

Background:

• Urinary tract infections (UTIs) are common, with symptomatic bladder bacteriuria requiring effective treatment.
• The pharmacokinetic properties of urinary antiseptics influence their efficacy and application in UTI management.

Purpose of the Study:

• To review the advantages and disadvantages of various urinary tract antiseptics.
• To evaluate their effectiveness in treating acute, uncomplicated, and recurrent UTIs.
• To assess their role in prophylaxis and in specific patient populations.

Main Methods:

• Comparative review of pharmacokinetic profiles and clinical efficacy of selected urinary tract antiseptics.
• Analysis of resistance development and therapeutic advantages of different agents and combinations.

Main Results:

• Nitrofurantoin demonstrates versatility, effective for upper tract infections, recurrent bacteriuria, and long-term suppression in children and pregnant patients with low resistance.
• Methenamine is effective for recurrent UTIs in females and prophylaxis in males, even with resistant pathogens; combination with acids shows no added benefit.
• Nalidixic acid and oxolinic acid are effective for acute UTIs and potentially recurrent infections, but require sensitivity monitoring due to resistance concerns.

Conclusions:

• Urinary tract antiseptics offer valuable therapeutic options for symptomatic bladder bacteriuria.
• Nitrofurantoin and methenamine present distinct advantages for various UTI types and patient groups.
• The cost-effectiveness of certain agents may increase their future utility, especially compared to prophylactic antibiotics like sulfamethoxazole-trimethoprim.